{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T03:07:16Z","timestamp":1726024036524},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T00:00:00Z","timestamp":1249603200000},"content-version":"vor","delay-in-days":8195,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1987,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intravenous flecainide acetate (2 mg\/kg) was administered to 40 patients undergoing routine electrophysiological evaluation for the investigation of recurrent paroxysmal tachycardias. Ten patients had recurrent atrial flutter, 11 patients had recurrent atrial fibrillation, one of whom also had paroxysmal left atrial tachycardia, and 19 patients had recurrent ventricular tachyarrhythmias (17 with recurrent ventricular tachycardia and 2 with recurrent fascicular tachycardia). Flecainide was administered during tachycardia (over 5 to 10 minutes) to all patients with atrial flutter, to 10 patients with atrial fibrillation, and to 17 patients with ventricular tachyarrythmias. In the remaining 3 patients with illsustained arrhythmias flecainide was administered during sinus rhythm and reinitiation of tachycardia was then attempted. Flecainide restored sinus rhythm in only 2 patients with atrial flutter (20%), in 9 patients with atrial fibrillation (90%), in 12 patients with ventricular tachycardia (80%), and in one of the 2 patients with fasicular tachycardia. Flecainide also successfully terminated the left atrial tachycardia. Two patients experienced proarrhythmic side effects during flecainide administration, one of whom required intervention by cardioversion. Minor dose effects included oral paresthesia, transient drowsiness or dizziness, and occasional visual blurring. Flecainide acetate is an effective antiarrhythmic agent for the acute termination of recent onset paroxysmal atrial and ventricular tachyarrhythmias.<\/jats:p>","DOI":"10.1002\/clc.4960100505","type":"journal-article","created":{"date-parts":[[2009,8,8]],"date-time":"2009-08-08T09:21:45Z","timestamp":1249723305000},"page":"317-322","source":"Crossref","is-referenced-by-count":12,"title":["Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias"],"prefix":"10.1002","volume":"10","author":[{"given":"A. W.","family":"Nathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Hellestrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"Bexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Hellestrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.eurheartj.a061432","article-title":"A comparison of the antiarrhythmic effects on AV junctional reentrant tachycardia of oral and intravenous flecainide acetate","volume":"4","author":"Bexton RS","year":"1983","journal-title":"Eur Heart J"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(77)80018-5"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.986"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.971"},{"key":"e_1_2_1_6_2","first-page":"315","volume-title":"Cardiac Arrhythmias\u2014A Decade of Progress","author":"Harrison DC","year":"1981"},{"key":"e_1_2_1_7_2","first-page":"449","volume-title":"Symposium on Cardiac Arrhythmias","author":"Williams Vaughan EM","year":"1970"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00216a016"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-197907000-00005"},{"key":"e_1_2_1_10_2","first-page":"775","article-title":"Some antiarrhythmic actions of a new compound, R\u2010818, in dogs and mice (abstr)","volume":"34","author":"Schmid JR","year":"1975","journal-title":"Fed Proc"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-197907000-00010"},{"key":"e_1_2_1_12_2","first-page":"II\u2010246","article-title":"Flecainide (R\u2010818), a new antiarrhythmic agent: Effects on ventricular premature beats (abstr)","volume":"58","author":"Hoback J.","year":"1978","journal-title":"Circulation"},{"key":"e_1_2_1_13_2","unstructured":"OrningOM:Electrophysiological effects of flecainide acetate in arrhythmias. InProceedings of VIII World Congress of Cardiology Tokyo (abstr) 480(1978)"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.65"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.48.2.140"},{"key":"e_1_2_1_16_2","first-page":"524","article-title":"Elecktrophysiologische effekte des neuen antiarrhythmikums flecainid (R818) beim menschen","volume":"70","author":"Seipel L.","year":"1981","journal-title":"Z Kardiol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb01023.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80131-3"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90518-4"},{"key":"e_1_2_1_20_2","first-page":"106","article-title":"The antiarrhythmic effects of intravenous disopyramide (abstr)","volume":"19","author":"Deano DA","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1978.tb02449.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6308.16"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-5223(19)37640-8","article-title":"Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations","volume":"81","author":"Installe E.","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/5.4.419"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5801.660"},{"key":"e_1_2_1_26_2","first-page":"82","article-title":"Acute termination of cardiac arrhythmias with intravenous disopyramide","volume":"4","author":"Mizgala HF","year":"1976","journal-title":"J Int Med Res"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.39.6.657"},{"key":"e_1_2_1_28_2","first-page":"3689","article-title":"Farmacologia e tossicologia della disopiramide","volume":"61","author":"Jequier R.","year":"1970","journal-title":"Minerva Med"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.5.602"},{"key":"e_1_2_1_30_2","volume-title":"Clinical Electrocardiography. Part 1. The Arrhythmias","author":"Katz LN","year":"1969"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-66356-7_7"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(77)80218-X"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)92413-4"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)92412-2"},{"key":"e_1_2_1_35_2","first-page":"II\u2010222","article-title":"Intravenous amiodarone in the acute treatment of recurrent ventricular tachycardia","volume":"66","author":"Morady F.","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90368-5"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90234-X"},{"key":"e_1_2_1_38_2","first-page":"215","article-title":"Cardiac function after oral dosing with flecainide acetate (abstr)","volume":"29","author":"Hodges M.","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960100505","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960100505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T10:23:50Z","timestamp":1697797430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960100505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,3]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,3]]}},"alternative-id":["10.1002\/clc.4960100505"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960100505","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,3]]}}}